2 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Nov 28, 2024
3 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Aug 05, 2024
Read More Medical New Treatment For Childhood Brain Tumours, Tovorafenib, Shows Promising Results With An Efficiency Rate Of 91%! Dec 18, 2024
Read More Disease Sudden Red Spots On Your Skin? Beware Of The "Undead Cancer", Be Alert To These Signs Dec 15, 2024
